Known targets — ChEMBL curated mechanism
S1PR1S1PR2S1PR3S1PR4S1PR5rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Thiamine Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | TKT | P29401 | 10/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thiamine Ion SCHEMBL1499696 | 1.00 | HSP90AA1 (0.68) | HSP90AA1TDP1TKTLMNAALDH1A1 | |
| Thiamine Ion SCHEMBL6274356 | 1.00 | HSP90AA1 (0.68) | HSP90AA1TDP1TKTLMNAALDH1A1 | |
| Thiamine Ion SCHEMBL1499697 | 0.99 | HSP90AA1 (0.67) | HSP90AA1TDP1TKTLMNAALDH1A1 | |
| Thiamine Ion SCHEMBL6274357 | 0.99 | HSP90AA1 (0.67) | HSP90AA1TDP1TKTLMNAALDH1A1 | |
| Thiamine Ion SCHEMBL7786248 | 0.98 | HSP90AA1 (0.66) | HSP90AA1TDP1TKTLMNAALDH1A1 | |
| Thiamine Ion SCHEMBL29908533 | 0.97 | HSP90AA1 (0.64) | HSP90AA1TDP1TKTLMNAALDH1A1 | |
| Thiamine Ion SCHEMBL6831590 | 0.92 | HSP90AA1 (0.69) | HSP90AA1TDP1TKTLMNAALDH1A1 | |
| Thiamine Ion SCHEMBL5329756 | 0.92 | HSP90AA1 (0.69) | HSP90AA1TDP1TKTLMNAALDH1A1 | |
| Thiamine Ion SCHEMBL6274353 | 0.92 | HSP90AA1 (0.68) | HSP90AA1TDP1TKTLMNAALDH1A1 | |
| Thiamine Ion SCHEMBL28650146 | 0.92 | HSP90AA1 (0.68) | HSP90AA1TDP1TKTLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12557829-B2 | Liquid-phase, supplementary feed composition containing coenzyme Q10 | YU HYO GYOUNG (KR) | 2026-02-24 | — | — | US | claimed |
| US-20240148026-A1 | LIQUID-PHASE, SUPPLEMENTARY FEED COMPOSITION CONTAINING COENZYME Q10 | YU HYO GYOUNG (KR) | 2024-05-09 | — | — | US | claimed |
| US-12557829-B2 | Liquid-phase, supplementary feed composition containing coenzyme Q10 | YU HYO GYOUNG (KR) | 2026-02-24 | — | — | US | disclosed |
| EP-4563003-A1 | KOREAN SAUCE MANUFACTURING METHOD | FoodBerry Co., Ltd. (KR) | 2025-06-04 | — | — | EP | disclosed |
| US-20250024870-A1 | NATURAL SUGAR-FREE SYRUP, AND PRODUCTION METHOD THEREOF | CJ CHEILJEDANG CORPORATION (KR) | 2025-01-23 | — | — | US | disclosed |
| EP-3566589-B1 | METHOD FOR PRODUCING MEAT BROTH COMPOSITION | CJ CHEILJEDANG CORP (KR) | 2024-12-11 | — | — | EP | disclosed |
| EP-4434356-A1 | NATURAL SUGAR-FREE SYRUP, AND PRODUCTION METHOD THEREOF | CJ CheilJedang Corporation (KR) | 2024-09-25 | — | — | EP | disclosed |
| US-20240148026-A1 | LIQUID-PHASE, SUPPLEMENTARY FEED COMPOSITION CONTAINING COENZYME Q10 | YU HYO GYOUNG (KR) | 2024-05-09 | — | — | US | disclosed |
| WO-2023101397-A1 | NATURAL SUGAR-FREE SYRUP, AND PRODUCTION METHOD THEREOF | 씨제이제일제당 (주) | 2023-06-08 | — | — | WO | disclosed |
| WO-2023080740-A1 | LIQUID COMPOSITION CONTAINING LUTEIN AS ACTIVE INGREDIENT, AND FEED COMPOSITION | 유효경 | 2023-05-11 | — | — | WO | disclosed |
| EP-3494798-B1 | METHOD FOR STERILIZING PROCESSED FOODS COMPRISING MICROWAVE HEATING PRETREATMENT | CJ CHEILJEDANG CORP (KR) | 2023-01-11 | — | — | EP | disclosed |
| WO-2022196943-A2 | LIQUID-PHASE, SUPPLEMENTARY FEED COMPOSITION CONTAINING COENZYME Q10 | 유효경 | 2022-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12557829-B2 | Liquid-phase, supplementary feed composition containing coenzyme Q10 | CPT2, CPT1B, SLC25A20 | HSP90AA1 2609/4885TDP1 2250/4885TKT 683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.